Intermolecular Interactions in Crystal Structures of Imatinib-Containing Compounds

Imatinib, one of the most used therapeutic agents to treat leukemia, is an inhibitor that specifically blocks the activity of tyrosine kinases. The molecule of imatinib is flexible and contains several functional groups able to take part in H-bonding and hydrophobic interactions. Analysis of molecul...

Full description

Bibliographic Details
Main Authors: Anna V. Vologzhanina, Ivan E. Ushakov, Alexander A. Korlyukov
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:International Journal of Molecular Sciences
Subjects:
API
Online Access:https://www.mdpi.com/1422-0067/21/23/8970
id doaj-b3344d4149194e05b55b8c2467c352e5
record_format Article
spelling doaj-b3344d4149194e05b55b8c2467c352e52020-11-27T08:08:42ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-11-01218970897010.3390/ijms21238970Intermolecular Interactions in Crystal Structures of Imatinib-Containing CompoundsAnna V. Vologzhanina0Ivan E. Ushakov1Alexander A. Korlyukov2A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilova str, 119991 Moscow, RussiaA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilova str, 119991 Moscow, RussiaA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilova str, 119991 Moscow, RussiaImatinib, one of the most used therapeutic agents to treat leukemia, is an inhibitor that specifically blocks the activity of tyrosine kinases. The molecule of imatinib is flexible and contains several functional groups able to take part in H-bonding and hydrophobic interactions. Analysis of molecular conformations for this drug was carried out using density functional theory calculations of rotation potentials along single bonds and by analyzing crystal structures of imatinib-containing compounds taken from the Cambridge Structural Database and the Protein Data Bank. Rotation along the N-C bond in the region of the amide group was found to be the reason for two relatively stable molecular conformations, an extended and a folded one. The role of various types of intermolecular interactions in stabilization of the particular molecular conformation was studied in terms of (i) the likelihood of H-bond formation, and (ii) their contribution to the Voronoi molecular surface. It is shown that experimentally observed hydrogen bonds are in accord with the likelihood of their formation. The number of H-bonds in ligand-receptor complexes surpasses that in imatinib salts due to the large number of donors and acceptors of H-bonding within the binding pocket of tyrosine kinases. Contribution of hydrophilic intermolecular interactions to the Voronoi molecular surface is similar for both conformations, while π...π stacking is more typical for the folded conformation of imatinib.https://www.mdpi.com/1422-0067/21/23/8970APIDFT calculationslikelihood of H-bond formationmolecular Voronoi polyhedron
collection DOAJ
language English
format Article
sources DOAJ
author Anna V. Vologzhanina
Ivan E. Ushakov
Alexander A. Korlyukov
spellingShingle Anna V. Vologzhanina
Ivan E. Ushakov
Alexander A. Korlyukov
Intermolecular Interactions in Crystal Structures of Imatinib-Containing Compounds
International Journal of Molecular Sciences
API
DFT calculations
likelihood of H-bond formation
molecular Voronoi polyhedron
author_facet Anna V. Vologzhanina
Ivan E. Ushakov
Alexander A. Korlyukov
author_sort Anna V. Vologzhanina
title Intermolecular Interactions in Crystal Structures of Imatinib-Containing Compounds
title_short Intermolecular Interactions in Crystal Structures of Imatinib-Containing Compounds
title_full Intermolecular Interactions in Crystal Structures of Imatinib-Containing Compounds
title_fullStr Intermolecular Interactions in Crystal Structures of Imatinib-Containing Compounds
title_full_unstemmed Intermolecular Interactions in Crystal Structures of Imatinib-Containing Compounds
title_sort intermolecular interactions in crystal structures of imatinib-containing compounds
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2020-11-01
description Imatinib, one of the most used therapeutic agents to treat leukemia, is an inhibitor that specifically blocks the activity of tyrosine kinases. The molecule of imatinib is flexible and contains several functional groups able to take part in H-bonding and hydrophobic interactions. Analysis of molecular conformations for this drug was carried out using density functional theory calculations of rotation potentials along single bonds and by analyzing crystal structures of imatinib-containing compounds taken from the Cambridge Structural Database and the Protein Data Bank. Rotation along the N-C bond in the region of the amide group was found to be the reason for two relatively stable molecular conformations, an extended and a folded one. The role of various types of intermolecular interactions in stabilization of the particular molecular conformation was studied in terms of (i) the likelihood of H-bond formation, and (ii) their contribution to the Voronoi molecular surface. It is shown that experimentally observed hydrogen bonds are in accord with the likelihood of their formation. The number of H-bonds in ligand-receptor complexes surpasses that in imatinib salts due to the large number of donors and acceptors of H-bonding within the binding pocket of tyrosine kinases. Contribution of hydrophilic intermolecular interactions to the Voronoi molecular surface is similar for both conformations, while π...π stacking is more typical for the folded conformation of imatinib.
topic API
DFT calculations
likelihood of H-bond formation
molecular Voronoi polyhedron
url https://www.mdpi.com/1422-0067/21/23/8970
work_keys_str_mv AT annavvologzhanina intermolecularinteractionsincrystalstructuresofimatinibcontainingcompounds
AT ivaneushakov intermolecularinteractionsincrystalstructuresofimatinibcontainingcompounds
AT alexanderakorlyukov intermolecularinteractionsincrystalstructuresofimatinibcontainingcompounds
_version_ 1724413733170577408